99mTc radiolabeling of polyethylenimine capped carbon dots for tumor targeting: synthesis, characterization and biodistribution

Purpose Due to the favorable physicochemical properties and the biocompatibility, carbon dots (CDs) have gained a great attention as a tumor targeting agent. This study investigates polyethylenimine capped CDs (PEI capped CDs) as a prospective nanocarrier of technetium-99m (Tc-99m) for tumor targeting. Technetium-labeled CDs could be introduced as a promising candidate for single photon emission tomography (SPECT) imaging. Materials and methods Polyethylenimine capped CDs were prepared by hydrothermal method using hyperbranched PEI and citric acid. For a purpose of comparison, citrate capped CDs were also prepared by microwave irradiation. Both types of CDs were characterized and radiolabeled with Tc-99m using sodium borohydride (NaBH4) as a reducing agent. Biodistribution and tumor targeting efficiency of the produced radiolabeled CDs have been studied in Earlich ascites tumor mice model. Results Citrate capped CDs and PEI capped CDs have been synthesized successfully and characterized. High radiochemical yield of Tc-99m-citrate capped CDs Tc-99m-PEI capped CDs was obtained (97 +/- 0.7 and 90 +/- 0.2, respectively). Biodistribution studies of Tc-99m-labeled PEI capped CDs have shown a potential tumor uptake (10 +/- 0.5% Radioactivity/gram tumor) with high target to non-target ratio (T/NT) around 7 at 1-h post injection. Tc-99m-citrate capped CDs have achieved a lower tumor uptake level (3.8 +/- 0.3% Radioactivity/gram tumor 1 h post injection). Conclusion This study introduces PEI capped CDs as a promising nanocarrier of Tc-99m for efficient tumor targeting. Technetium-labeled PEI capped CDs could be utilized as a potential SPECT tumor imaging agent.

Automated summary

Carbon dots (CDs) have gained attention as a tumor targeting agent due to their favorable physicochemical properties and biocompatibility. Polyethylenimine capped CDs were successfully synthesized as a potential nanocarrier for Technetium-99m (Tc-99m) with promising tumor targeting efficiency. Tc-99m-labeled PEI capped CDs showed potential as a SPECT tumor imaging agent with high tumor uptake and target to non-target ratio.